Moneycontrol
HomeNewsBusinessEconomyDownward revision of growth by agencies shows lockdown impact; June data points to uptick: EY

Downward revision of growth by agencies shows lockdown impact; June data points to uptick: EY

EY's current assessment of India's 2020-21 real gross value added (GVA) growth is 1.9 per cent provided that India sticks to its infrastructure funding plans.

July 08, 2020 / 22:00 IST
Story continues below Advertisement

The sharp downward revision in growth projections by various national and international agencies indicates the impact of the coronavirus-induced lockdown and inadequate stimulus package, EY said on Wednesday adding that June economic indicators show an uptick in activity.

EY's current assessment of India's 2020-21 real gross value added (GVA) growth is 1.9 per cent provided that India sticks to its infrastructure funding plans.

Story continues below Advertisement

Stating that high-frequency indicators signal slow but steady turnaround, EY said PMI manufacturing and services index, power consumption and forex reserves showed improvement in June. Also, GST collection increased to Rs 90,917 crore in June, from Rs 62,009 crore and Rs 32,294 crore in May and April, respectively.

Speaking at the EY webinar on 'Rejuvenating Growth - Economic and Trade Policy Pathways', EY Indian Chief Policy Advisor D K Srivastava said India's fiscal stimulus at 1.2 per cent of GDP is the third lowest among the major economies of the world, but hoped that as more fiscal space gets created there could be another round of stimulus towards the later part of the financial year.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show